Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content.

The FDA is reviewing iberdomide for relapsed or refractory multiple myeloma, with a decision date set for August. The U.S. Food and Drug Administration (FDA) has accepted a new drug application for ...

The trailer for “A Prayer for the Dying,” which stars Johnny Flynn, John C. Reilly and Kristine Kujath Thorp, has launched ahead of the world premiere on Friday in Berlinale’s Perspectives section.

With their resistance to violent authoritarianism, the people of Minneapolis have renewed the spirit of Dr. King’s call for “the positive affirmation of peace.” With their resistance to violent ...

The FDA approved Darzalex Faspro with VRd for newly diagnosed multiple myeloma patients ineligible for ASCT, based on the CEPHEUS trial results. The CEPHEUS trial showed improved MRD negativity rates ...

Luciano Costa waited three years to see how patients with an aggressive bone-marrow cancer would fare on an experimental immunotherapy treatment. Reviewing the results gave him goose bumps. “Holy shit ...

In this post, we will show you how to create real-time interactive flowcharts for your code using VS Code CodeVisualizer. CodeVisualizer is a free, open-source Visual Studio Code extension that ...

The FDA has “proactively” granted Johnson & Johnson a coveted speedy review under the Commissioner’s National Priority Voucher pilot (CNPV), the agency said Monday. The voucher was granted to J&J for ...

Looking for the best places to retire outside the U.S.? International Living’s 2026 Annual Global Retirement Index, now in its 35th year, identifies “the best global destinations for a rewarding, ...

The “ShamWow guy” who for years graced Americans’ screens with his towel infomercials is running for Congress, where he vows he would combat “wokeism” in the U.S. Offer Vince Shlomi, 61, tells TIME ...

Researchers at Google have developed a new AI paradigm aimed at solving one of the biggest limitations in today’s large language models: their inability to learn or update their knowledge after ...